...
首页> 外文期刊>Multiple sclerosis: clinical and laboratory research >The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
【24h】

The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.

机译:多发性硬化症患者中促炎和营养因子的平衡:急性复发和免疫调节治疗的影响。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: In multiple sclerosis inflammation is primarily injurious to the central nervous system, but its therapeutic suppression might inhibit repair-promoting factors. OBJECTIVES: We aimed at better describing the complexity of biological effects during an acute relapse and analysed the effects of intervention with high-dose i.v. glucocorticoids and immunomodulatory treatment with interferon-beta (IFNbeta). METHODS: We studied the intracellular expression levels of the pro-inflammatory mediators tumour necrosis factor alpha (TNFalpha) and inducible nitric oxide synthase (iNOS) together with the neurotrophins ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) in freshly isolated peripheral blood mononuclear cells of multiple sclerosis patients during an acute relapse, after intervention with i.v. methylprednisolone and at baseline, using a highly quantitative flow-cytometric approach. RESULTS: We demonstrated the expression of CNTF in human leucocytes. We showed that CNTF levels differed in acutely relapsing multiple sclerosis patients compared with controls and increased after corticosteroid treatment. CNTF can counteract the toxicity of TNFalpha towards oligodendrocytes and we found TNFalpha increased during acute relapses. Following corticosteroids, neither TNFalpha nor iNOS expression was reduced. Levels of BDNF were not affected by glucocorticoids, but increased during IFNbeta therapy. However, IFNbeta also increased the expression of iNOS and major histocompatibility complex class I (MHC-I), underlining its immunomodulatory potential. CONCLUSIONS: Multiple sclerosis patients might benefit from reparative, and not solely from anti-inflammatory, effects of glucocorticoids. Interactive effects of glucocorticoid- and IFNbeta-treatment need to be considered to improve neuroprotection and remyelination resulting from immunomodulatory treatment.
机译:背景:在多发性硬化症中,炎症主要损害中枢神经系统,但其治疗抑制作用可能会抑制促进修复的因子。目的:我们旨在更好地描述急性复发期间生物学效应的复杂性,并分析了大剂量静脉内注射的干预作用。糖皮质激素和干扰素-β(IFNbeta)的免疫调节治疗。方法:我们研究了促炎介质肿瘤坏死因子α(TNFalpha)和诱导型一氧化氮合酶(iNOS)以及神经营养因子睫状神经营养因子(CNTF)和脑源性神经营养因子(BDNF)在细胞内的表达水平。静脉干预后多发性硬化症患者急性复发期间分离的外周血单个核细胞甲基强的松龙,在基线时,采用高度定量的流式细胞术。结果:我们证明了CNTF在人白细胞中的表达。我们显示,与对照组相比,急性复发性多发性硬化症患者的CNTF水平有所不同,皮质类固醇激素治疗后CNTF水平升高。 CNTF可以抵消TNFα对少突胶质细胞的毒性,我们发现TNFα在急性复发期间会增加。糖皮质激素治疗后,TNFalpha和iNOS表达均未降低。 BDNF的水平不受糖皮质激素的影响,但在IFNbeta治疗期间升高。但是,IFNbeta也增加了iNOS和主要组织相容性复合物I类(MHC-1)的表达,突显了其免疫调节潜力。结论:多发性硬化症患者可能受益于糖皮质激素的修复作用,而不仅是抗炎作用。需要考虑糖皮质激素和IFNβ治疗的相互作用,以改善免疫调节治疗引起的神经保护和髓鞘再生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号